Drug Information

Drug General Information
Drug ID
D0KP5N
Former ID
DNC001044
Drug Name
RJW-57926
Drug Type
Small molecular drug
Indication Eating disorder; Obesity [ICD9: 278, 307.5; ICD10:E66, F50] Investigative [536225]
Company
RW Johnson Pharmaceutical Research Institute
Structure
Download
2D MOL

3D MOL
Formula
C30H31N3O
Canonical SMILES
C1=CC=C(C=C1)C(CCOC2=CC=C(C=C2)CCN=C(N)N)(C3=CC=CC=C3)C<br />4=CC=CC=C4
InChI
1S/C30H31N3O/c31-29(32)33-22-20-24-16-18-28(19-17-24)34-23-21-30(25-10-4-1-5-11-25,26-12-6-2-7-13-26)27-14-8-3-9-15-27/h1-19H,20-23H2,(H4,31,32,33)
InChIKey
AJKCPFPHDCULCG-UHFFFAOYSA-N
CAS Number
CAS 6508-43-6
PubChem Compound ID
516731
PubChem Substance ID
818608, 14857584, 39346012, 80732682, 109756241, 134340301, 134340456, 225017885, 238336784, 248074805
Target and Pathway
Target(s) Neuropeptide Y receptor 5 Target Info Antagonist [536225]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Peptide ligand-binding receptors
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 536225Emerging drugs for eating disorder treatment. Expert Opin Emerg Drugs. 2006 May;11(2):315-36.
Ref 536225Emerging drugs for eating disorder treatment. Expert Opin Emerg Drugs. 2006 May;11(2):315-36.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.